# Efficacy and Safety of Defocusing Frame Glasses With Artificial Intelligence in Controlling Myopia Progression

> **NCT05532774** · NA · UNKNOWN · sponsor: **Shanghai Eye Disease Prevention and Treatment Center** · enrollment: 138 (estimated)

## Conditions studied

- Myopia

## Interventions

- **DEVICE:** AI defocusing frame glasses

## Key facts

- **NCT ID:** NCT05532774
- **Lead sponsor:** Shanghai Eye Disease Prevention and Treatment Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-12
- **Primary completion:** 2024-09-12
- **Final completion:** 2024-11-30
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2022-10-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05532774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05532774, "Efficacy and Safety of Defocusing Frame Glasses With Artificial Intelligence in Controlling Myopia Progression". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05532774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*